Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (261-270 of 353) with videos related to

Pageof 36
Sort By:
JAMA|November 20, 2013
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trialStephen J Nicholls, John J P Kastelein, Gregory G Schwartz, et al.
Circulation. Heart Failure|January 26, 2024
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and ObesityAmgad Mentias, Milind Y Desai, Ali Aminian, et al.
Journal of the American College of Cardiology|April 21, 2018
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or IbuprofenGrant W Reed, Mouin S Abdallah, Mingyuan Shao, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2018
Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary SyndromeBarbara E Stähli, Anna Nozza, Ilse C Schrieks, et al.
American Heart Journal|September 11, 2020
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designDonna H Ryan, Ildiko Lingvay, Helen M Colhoun, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
Journal of the American Heart Association|November 3, 2022
Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary InterventionAnirudh Kumar, Gregory O Ogunnowo, Umesh N Khot, et al.
Resuscitation Plus|August 4, 2021
Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCIAnirudh Kumar, Leon Zhou, Chetan P Huded, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical TrialDaniel H Solomon, M Elaine Husni, Katherine E Wolski, et al.
Nature Medicine|April 2, 2026
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trialSebastian M Meyhöfer, Bertrand Cariou, Cintia Cercato, et al.
Pageof 36

Showing results (261-270 of 353) with videos related to

Sort By:
Pageof 36
JAMA|November 20, 2013
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trialStephen J Nicholls, John J P Kastelein, Gregory G Schwartz, et al.
Circulation. Heart Failure|January 26, 2024
Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and ObesityAmgad Mentias, Milind Y Desai, Ali Aminian, et al.
Journal of the American College of Cardiology|April 21, 2018
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or IbuprofenGrant W Reed, Mouin S Abdallah, Mingyuan Shao, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2018
Homeostasis Model Assessment of Insulin Resistance and Survival in Patients With Diabetes and Acute Coronary SyndromeBarbara E Stähli, Anna Nozza, Ilse C Schrieks, et al.
American Heart Journal|September 11, 2020
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and designDonna H Ryan, Ildiko Lingvay, Helen M Colhoun, et al.
JACC. Cardiovascular Interventions|June 25, 2011
Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trialsRoxana Mehran, Stuart Pocock, Eugenia Nikolsky, et al.
Journal of the American Heart Association|November 3, 2022
Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary InterventionAnirudh Kumar, Gregory O Ogunnowo, Umesh N Khot, et al.
Resuscitation Plus|August 4, 2021
Prognostic implications and outcomes of cardiac arrest among contemporary patients with STEMI treated with PCIAnirudh Kumar, Leon Zhou, Chetan P Huded, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2017
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis: A Randomized Clinical TrialDaniel H Solomon, M Elaine Husni, Katherine E Wolski, et al.
Nature Medicine|April 2, 2026
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trialSebastian M Meyhöfer, Bertrand Cariou, Cintia Cercato, et al.
Pageof 36